Torigen Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 22

Employees

  • Latest Deal Type
  • Series A1

  • Latest Deal Amount
  • $4.28M

  • Investors
  • 23

Torigen General Information

Description

Operator of an immunotherapy cancer treatment company intended to detect and treat cancer among animals. The company's experimental autologous cancer vaccine activates the immune system against specific tumor-associated antigens found on the outside surface of the tumor cells that are different from normal self-cells, enabling surgeons to detect and eliminate cancer among companion animals without having to depend on painful surgeries and chemotherapy.

Contact Information

Website
www.torigen.com
Formerly Known As
VetiVax
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 6 Executive Drive
  • Suite 118
  • Farmington, CT 06031
  • United States
+1 (860)
Primary Industry
Other Commercial Products
Vertical(s)
Pet Technology
Corporate Office
  • 6 Executive Drive
  • Suite 118
  • Farmington, CT 06031
  • United States
+1 (860)

Torigen Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Torigen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Later Stage VC (Series A1) 14-May-2024 $4.28M Completed Generating Revenue
13. Later Stage VC 22-Jun-2023 Completed Generating Revenue
12. Later Stage VC (Series A1) 16-Nov-2022 Completed Generating Revenue
11. Accelerator/Incubator 01-Nov-2019 Completed Generating Revenue
10. Later Stage VC (Series A) 04-Jan-2019 Completed Generating Revenue
9. Grant 06-Sep-2018 Completed Generating Revenue
8. Seed Round 30-Jul-2018 Completed Generating Revenue
7. Debt - General 18-May-2018 Completed Generating Revenue
6. Accelerator/Incubator 23-May-2017 Completed Startup
5. Accelerator/Incubator Completed Startup
To view Torigen’s complete valuation and funding history, request access »

Torigen Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A-1
Series A
To view Torigen’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Torigen Patents

  • 7

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 2

    Pending

  • Expiring in next 12 mo

Torigen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3190707-A1 Immune memory enhanced preparations and uses thereof Pending 28-Aug-2020
EP-4203994-A1 Immune memory enhanced preparations and uses thereof Inactive 28-Aug-2020
EP-4203994-A4 Immune memory enhanced preparations and uses thereof Inactive 28-Aug-2020
US-20220062406-A1 Immune memory enhanced preparations and uses thereof Inactive 28-Aug-2020
US-20250057940-A1 Immune memory enhanced preparations and uses thereof Pending 28-Aug-2020 A61K39/215
To view Torigen’s complete patent history, request access »

Torigen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Torigen Investors (23)

Investor Name Investor Type Holding Investor Since Participating Rounds
Advantage Capital (Louisiana) PE/Buyout Minority
Aimers Venture Partners Venture Capital Minority
Chloe Capital Venture Capital Minority
Emerald Development Managers Venture Capital Minority
Gaingels Venture Capital Minority
You’re viewing 5 of 23 investors. Get the full list »

Ready to get started?

Request a free trial

Torigen FAQs

  • When was Torigen founded?

    Torigen was founded in 2013.

  • Where is Torigen headquartered?

    Torigen is headquartered in Farmington, CT.

  • What is the size of Torigen?

    Torigen has 22 total employees.

  • What industry is Torigen in?

    Torigen’s primary industry is Other Commercial Products.

  • Is Torigen a private or public company?

    Torigen is a Private company.

  • What is Torigen’s current revenue?

    The current revenue for Torigen is .

  • How much funding has Torigen raised over time?

    Torigen has raised $24.4M.

  • Who are Torigen’s investors?

    Advantage Capital (Louisiana), Aimers Venture Partners, Chloe Capital, Emerald Development Managers, and Gaingels are 5 of 23 investors who have invested in Torigen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process